MDD Treatment Disparities Across Patient Populations: Part 2

EP: 1.Unmet Needs in Treatment of MDD

EP: 2.MDD Treatment Landscape

EP: 3.Potential Consequences of Recurrent or Poorly Controlled MDD

EP: 4.Burden of Treatment Failure in MDD

EP: 5.Importance of Early Effective Treatment of MDD

EP: 6.Evaluating MDD Treatment Attributes

EP: 7.Considerations for Newly Launched MDD Treatments

EP: 8.Healthcare Disparities Within Major Depressive Disorder

EP: 9.MDD Treatment Disparities Across Patient Populations

EP: 10.Social Determinants of Health in MDD

EP: 11.Impact of COVID-19 on Demand for Mental Health Services

EP: 12.Health Care Disparities Within Major Depressive Disorder (MDD)

Now Viewing

EP: 13.MDD Treatment Disparities Across Patient Populations: Part 2

EP: 14.Social Determinants of Health in MDD: Part 2

EP: 15.Population Health Approach in MDD

EP: 16.Factors Affecting MDD Treatment Adherence

EP: 17.Supporting Adherence for Patients with MDD

EP: 18.Aligning MDD Treatment Goals for Payers and Patients

EP: 19.The Impact of Early Effective Treatment in MDD

EP: 20.Key Contributors to Long-term Outcomes for Patients With MDD

Jay Weaver, PharmD, MPH: As we looked across our populations most affected by disparities of care in major depressive disorder, we noticed that 1 population had more isolation and maybe more limited access to care: persons of Medicare age. Some of our older populations have fewer people in their home or fewer people to care for them. That was 1 group that we noticed had some challenges. As we spoke about before, people of color also presented with especially big challenges in getting access to care and seeking care. The third population that we noticed had fewer specialized services available to them were some of our LGBTQ [lesbian, gay, bisexual, transgender, questioning] populations. They had a lack of specialized services for some of the things that they’re dealing with as they’re seeking health care services and finding people who can relate to their needs.

Mona Chitre, PharmD, CGP: I agree with Dr Weaver. There are a number of populations that have different and pronounced effects because they have different types of diagnosis, lack of access, and no clear treatment plan. There are differences in how they may be treated. I agree with Dr Weaver’s comments. The Black and brown populations, our pediatric patients, and sometimes our female patients all have disparities. We’re always looking at that from both a population perspective and a health plan perspective, ensuring equal treatment and trying to close some of those disparities.

Transcript edited for clarity.